Recombinant Pseudomonas putida Coenzyme PQQ synthesis protein D 1 (pqqD1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to ensure contents settle. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your preparations.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag will be determined during production. If you require a particular tag type, please specify this in your order; we will prioritize fulfilling your request.
Synonyms
pqqD1; PP_0377; PqqA binding protein 1; Coenzyme PQQ synthesis protein D 1; Pyrroloquinoline quinone biosynthesis protein D 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-91
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Pseudomonas putida (strain ATCC 47054 / DSM 6125 / NCIMB 11950 / KT2440)
Target Names
pqqD1
Target Protein Sequence
MSFDRNQVPN WRPGYRFQYE PAQKGHVLLY PEGMIKLNDS ASLIGGLIDG QRDVAAIISE LEQQFPGVPE VADDIEQFME VARAEHWIVL A
Uniprot No.

Target Background

Function
Functions as a PqqA-binding protein, facilitating the presentation of PqqA to PqqE within the pyrroloquinoline quinone (PQQ) biosynthetic pathway.
Database Links

KEGG: ppu:PP_0377

STRING: 160488.PP_0377

Protein Families
PqqD family

Q&A

What is Pyrroloquinoline Quinone (PQQ) and why is it biochemically significant?

Pyrroloquinoline quinone (PQQ) functions as a prominent redox cofactor in many prokaryotic organisms. It is produced from a ribosomally synthesized peptide (PqqA) that undergoes extensive post-translational modifications through a pathway comprising at least four conserved proteins: PqqB–E . PQQ's biochemical significance stems from its exceptional redox properties, serving as an electron carrier in various dehydrogenases, particularly in methanol dehydrogenase systems of methylotrophic bacteria. As a redox-active molecule, PQQ can undergo multiple oxidation-reduction cycles without degradation, making it particularly valuable for biocatalytic applications and metabolic engineering efforts .

What is the function of pqqD1 in the PQQ biosynthetic pathway?

PqqD1 functions as a peptide chaperone in the PQQ biosynthetic pathway. It specifically binds to and stabilizes the PqqA peptide, which is the precursor for PQQ biosynthesis. This chaperoning activity is crucial for ensuring that PqqA adopts the correct conformation for further processing by PqqE, which performs radical SAM-mediated cross-linking of specific amino acid residues in PqqA . The interaction between PqqD and PqqE facilitates the initial steps of PQQ biosynthesis by ensuring proper substrate presentation, essentially acting as a molecular scaffold for the early biosynthetic reactions .

How does the PQQ biosynthesis gene organization differ across bacterial species?

The PQQ biosynthesis genes exhibit variable organization across different bacterial species. In Methylorubrum extorquens (formerly Methylobacterium extorquens), the PQQ genes are arranged in two clusters: pqqDGCBA and pqqEF . This differs from the organization in other organisms like Klebsiella pneumoniae, where the genes are arranged as pqqABCDE . In Pseudomonas putida, the gene arrangement follows a pattern that enables efficient expression and regulation of the PQQ biosynthetic machinery. The genomic context of these genes often reflects their co-regulation and functional relationships, with the core biosynthetic genes (pqqA-E) typically clustered together while auxiliary genes like pqqF and pqqG may be located elsewhere in the genome .

What are the optimal conditions for recombinant expression of pqqD1 in heterologous hosts?

For recombinant expression of pqqD1 from Pseudomonas putida, the most successful approach involves chromosomal integration rather than plasmid-based expression. Based on successful heterologous expression systems for other P. putida proteins, optimal conditions include:

  • Host Selection: Escherichia coli BL21(DE3) provides high expression yields for initial protein production, though P. putida KT2440 itself can be used for homologous expression to ensure proper folding .

  • Temperature Control: Expression at lower temperatures (20°C) significantly improves protein solubility and proper folding, as demonstrated in similar recombinant protein expression studies with P. putida .

  • Media Composition: Rich media under high aeration conditions supports optimal expression, resembling conditions that yielded 94 mg/L of recombinant protein in similar P. putida expression systems .

  • Induction Parameters: For IPTG-inducible systems, concentrations of 0.1-0.5 mM IPTG typically provide sufficient induction while minimizing formation of inclusion bodies.

  • Codon Optimization: Adaptation of the pqqD1 gene sequence to match the codon usage preferences of the expression host significantly improves translation efficiency.

The use of fusion tags (such as His6, MBP, or SUMO) improves both solubility and facilitates purification. The optimal tag should be determined experimentally, as different proteins respond differently to various fusion partners .

What methods are most effective for purifying recombinant pqqD1?

Based on protocols established for similar proteins in the PQQ biosynthetic pathway, the most effective purification strategy for recombinant pqqD1 includes the following sequential steps:

  • Affinity Chromatography: If expressed with a His6-tag, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin provides high-specificity initial purification. Optimal elution conditions typically involve an imidazole gradient (20-250 mM).

  • Ion Exchange Chromatography: Following initial purification, ion exchange chromatography (typically anion exchange) helps remove remaining contaminants based on charge differences. For pqqD1, which functions as a peptide chaperone, buffer conditions at pH 7.5-8.0 often provide optimal separation.

  • Size Exclusion Chromatography: As a final polishing step, gel filtration separates any aggregates or impurities of different molecular weights, while also enabling buffer exchange to conditions optimal for downstream applications or storage.

  • Tag Removal: If necessary for functional studies, the affinity tag can be removed using specific proteases (TEV, PreScission, or thrombin), followed by a second affinity step to separate the cleaved protein from the tag and protease.

This multi-step approach typically yields >95% pure protein suitable for biochemical and structural studies. Protein quality should be verified by SDS-PAGE, Western blotting, and mass spectrometry .

What analytical techniques are used to confirm proper folding and activity of recombinant pqqD1?

Several complementary analytical techniques should be employed to verify both proper folding and functional activity of recombinant pqqD1:

  • Circular Dichroism (CD) Spectroscopy: CD provides information about secondary structure composition (α-helices, β-sheets) and can confirm that the recombinant protein has similar structural characteristics to native pqqD1.

  • Thermal Shift Assays: These provide information about protein stability and can be used to optimize buffer conditions for storage and functional studies.

  • Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS): This technique determines the oligomeric state of the protein in solution, which is important since proper oligomerization is often crucial for function.

  • Functional Binding Assays: Surface Plasmon Resonance (SPR) or Isothermal Titration Calorimetry (ITC) can be used to measure binding of pqqD1 to its substrate PqqA and partner protein PqqE. Similar techniques were used to demonstrate the formation of the PqqF/PqqG complex with a KD of 300 nM .

  • Pull-down Assays: In vitro pull-down experiments can verify interactions with other PQQ biosynthetic proteins, particularly PqqE, which works together with pqqD1 in processing PqqA .

  • Activity Assays: As pqqD1 functions as a peptide chaperone, its activity can be assessed by measuring its ability to protect PqqA from degradation or by measuring the efficiency of subsequent PqqE-catalyzed reactions in the presence versus absence of pqqD1.

These combined approaches provide comprehensive verification of both structural integrity and functional activity of the recombinant protein .

How does pqqD1 interact with other proteins in the PQQ biosynthetic pathway?

PqqD1 exhibits specific molecular interactions with multiple proteins in the PQQ biosynthetic pathway:

  • PqqA Interaction: PqqD1 functions primarily as a peptide chaperone for PqqA, the precursor peptide in PQQ biosynthesis. This interaction involves specific binding to PqqA to present it in the correct orientation for subsequent modifications. Studies of similar PqqD proteins suggest this binding typically occurs with nanomolar affinity .

  • PqqE Interaction: PqqD1 forms a functional complex with PqqE, the radical SAM enzyme that catalyzes the initial cross-linking of glutamate and tyrosine residues in PqqA. This interaction is essential for the early steps of PQQ biosynthesis and effectively creates a peptide-binding platform that positions PqqA correctly for the radical-based chemistry .

  • Potential Interactions with PqqF/PqqG: While not directly established for pqqD1, studies on the PQQ pathway in Methylorubrum extorquens revealed that the proteolytic system PqqF/PqqG (which cleaves the modified PqqA) may interact with the PqqD-PqqE-PqqA complex to coordinate the sequential processing steps .

The interaction network is temporally coordinated, with pqqD1 likely acting as a central scaffold that facilitates the sequential modifications of PqqA by presenting it to the appropriate enzymes in the correct orientation at each biosynthetic step .

What structural features of pqqD1 are essential for its chaperoning function?

The key structural features of pqqD1 that enable its peptide chaperoning function include:

  • Binding Pocket Architecture: PqqD1 contains a specialized binding pocket that accommodates the PqqA peptide substrate. This pocket likely includes hydrophobic regions for substrate stabilization as well as specific recognition elements for the amino acid sequence of PqqA.

  • Interface for PqqE Interaction: A defined interaction surface enables pqqD1 to form a complex with PqqE. This interface facilitates the transfer or presentation of the bound PqqA peptide to the active site of PqqE for radical-based cross-linking of specific residues.

  • Conserved Residues: Sequence alignment of pqqD1 with homologs from different bacterial species reveals conserved amino acids that are critical for function. These typically include specific residues involved in peptide binding and protein-protein interactions.

  • Structural Plasticity: Some evidence suggests that pqqD proteins undergo conformational changes upon substrate binding, which may be essential for their chaperoning function and for presenting the substrate correctly to partner enzymes.

Based on similar peptide chaperones, the three-dimensional structure likely adopts a compact fold with defined substrate-binding channels that specifically recognize the PqqA peptide while protecting it from premature degradation by cellular proteases .

What is the molecular mechanism of the PqqE-pqqD1 complex in cross-linking amino acids in PqqA?

The PqqE-pqqD1 complex executes a sophisticated radical-based chemistry to initiate PQQ biosynthesis:

  • Initial Complex Formation: PqqD1 first binds to the PqqA peptide substrate, forming a stable complex that protects PqqA from degradation and positions it correctly for processing.

  • PqqE Recruitment: The PqqD1-PqqA complex then associates with PqqE, a radical SAM enzyme containing an iron-sulfur cluster. This forms a ternary complex where the substrate is optimally positioned relative to the enzyme active site.

  • Radical Generation: PqqE uses its Fe-S cluster and S-adenosylmethionine (SAM) to generate a highly reactive 5'-deoxyadenosyl radical. This radical species is the key reactive intermediate that initiates the cross-linking chemistry.

  • Cross-linking Reaction: The generated radical abstracts a hydrogen atom from specific residues in PqqA (typically a glutamate and a tyrosine), creating reactive carbon-centered radicals that subsequently couple to form a covalent cross-link between these amino acids.

  • Product Release: Following the cross-linking reaction, the modified PqqA (often referred to as PqqA*) is released from the complex and becomes a substrate for subsequent processing steps, including proteolytic cleavage by the PqqF/PqqG protease system.

This mechanism represents a remarkable example of how radical-based enzymology is employed in biosynthetic pathways to create complex molecular structures .

How can isotope labeling of pqqD1 facilitate structural and mechanistic studies?

Isotope labeling of pqqD1 provides powerful approaches for detailed structural and mechanistic investigations:

  • NMR Spectroscopy Applications:

    • Uniform 15N or 13C/15N labeling enables high-resolution solution NMR studies to determine the three-dimensional structure of pqqD1.

    • Selective amino acid labeling (particularly for residues at the active site or binding interfaces) allows for specific monitoring of key residues during substrate binding or protein-protein interactions.

    • TROSY-based experiments with deuterated and selectively protonated pqqD1 can provide insights into dynamics and conformational changes that occur during its chaperoning function.

  • Mass Spectrometry Applications:

    • Hydrogen/deuterium exchange mass spectrometry (HDX-MS) with deuterium-labeled pqqD1 can identify regions involved in substrate binding or protein-protein interactions by analyzing differential exchange rates.

    • Crosslinking mass spectrometry using isotopically labeled crosslinkers can map the topology of complexes formed between pqqD1 and other proteins in the PQQ biosynthetic pathway.

  • Mechanistic Studies:

    • 13C or 15N labeling of specific residues in both pqqD1 and its substrate PqqA enables tracking of molecular interactions and conformational changes using NMR or FTIR spectroscopy.

    • Pulse-chase experiments with isotopically labeled substrates can elucidate the kinetics of complex formation and substrate processing in the PQQ biosynthetic pathway.

  • Crystallography Enhancements:

    • Selenomethionine labeling facilitates X-ray crystallographic structure determination through multi-wavelength anomalous dispersion (MAD) phasing.

    • Neutron diffraction studies with deuterated pqqD1 can provide detailed information about hydrogen bonding networks that are critical for substrate recognition.

These isotope labeling approaches provide molecular-level understanding of how pqqD1 functions within the PQQ biosynthetic pathway .

What genetic engineering strategies can enhance pqqD1 expression and function in Pseudomonas putida?

Several advanced genetic engineering approaches can optimize pqqD1 expression and function:

  • Promoter Engineering:

    • Implementation of constitutive promoters derived from highly expressed P. putida genes can drive strong expression of pqqD1. This approach was successfully used for heterologous gene expression in P. putida, resulting in high production levels of recombinant proteins .

    • Development of fine-tuned inducible promoter systems, such as modified Pm promoters responding to benzoate derivatives, allows for controlled expression levels and timing.

  • Codon Optimization and mRNA Stabilization:

    • Adaptation of the pqqD1 coding sequence to the codon usage bias of P. putida can significantly enhance translation efficiency.

    • Engineering of the 5' untranslated region (UTR) to include optimal ribosome binding sites and mRNA secondary structures can increase translational efficiency.

    • Inclusion of stabilizing RNA elements can extend mRNA half-life and increase protein yield.

  • Chromosomal Integration Strategies:

    • Targeted integration into highly transcribed genomic loci using Tn5-based transposition systems, similar to the approach used for prodigiosin production, can achieve stable and high-level expression .

    • CRISPR-Cas9 mediated targeted integration can precisely position pqqD1 within the genome to optimize expression levels and minimize metabolic burden.

  • Protein Engineering for Enhanced Function:

    • Directed evolution approaches can be applied to generate pqqD1 variants with improved substrate binding, stability, or interaction with partner proteins.

    • Rational design based on structural data can enhance specific properties such as thermostability or substrate specificity.

  • Metabolic Engineering Context:

    • Co-expression of pqqD1 with other PQQ biosynthetic genes in optimized ratios can ensure balanced pathway flux.

    • Knockdown of competing pathways using CRISPRi approaches (as demonstrated in P. putida ) can redirect cellular resources toward PQQ biosynthesis.

These strategies, individually or in combination, can significantly enhance the expression and functional performance of pqqD1 in P. putida systems .

How can cryo-electron microscopy be used to elucidate the structure of pqqD1-containing multi-protein complexes?

Cryo-electron microscopy (cryo-EM) offers powerful approaches for structural characterization of pqqD1-containing complexes:

  • Single Particle Analysis for Complex Structures:

    • High-resolution structures (potentially reaching 2-3 Å) of pqqD1 in complex with larger proteins like PqqE can be determined using single-particle cryo-EM.

    • Time-resolved sampling can potentially capture different states of the complex during the catalytic cycle, providing insights into the dynamic aspects of pqqD1 function.

  • Sample Preparation Considerations:

    • Gradient fixation techniques (GraFix) can stabilize transient complexes between pqqD1 and its interaction partners for structural studies.

    • Various detergent or nanodisc approaches may be necessary if membrane association plays any role in the function of the complex.

    • Crosslinking strategies can be employed to stabilize particularly transient interactions, with MS/MS analysis confirming the specificity of crosslinks.

  • Multi-method Integration:

    • Combining cryo-EM with X-ray crystallography data from individual components allows for high-confidence atomic models of the complete assembly.

    • Integrative modeling approaches incorporating data from SAXS, mass spectrometry, and biochemical crosslinking can further refine structural models of dynamic regions.

  • Functional Analysis:

    • Correlative light and electron microscopy (CLEM) can provide insights into the cellular localization and context of pqqD1-containing complexes in vivo.

    • Particle classification algorithms can identify and analyze different conformational states that may correspond to distinct functional states in the catalytic cycle.

  • Technical Considerations:

    • The relatively small size of pqqD1 (~10 kDa) presents challenges for cryo-EM, but its incorporation into larger complexes with PqqE and other partners makes visualization feasible.

    • Phase plate technology significantly improves contrast for smaller complexes and can be essential for achieving high-resolution structures.

These cryo-EM approaches complement other structural methods and provide unique insights into the macromolecular assemblies involved in PQQ biosynthesis .

How does pqqD1 contribute to the metabolic versatility of Pseudomonas putida?

The pqqD1 protein contributes significantly to P. putida's metabolic versatility through multiple pathways:

The metabolic flexibility conferred by pqqD1 and other PQQ biosynthetic proteins aligns with P. putida's reputation as a versatile organism with exceptional biotechnological potential .

What is the relationship between PQQ biosynthesis and one-carbon metabolism in engineered P. putida strains?

The relationship between PQQ biosynthesis and one-carbon (C1) metabolism in engineered P. putida strains reveals sophisticated metabolic integration:

  • Enabling C1 Compound Oxidation:

    • PQQ serves as a cofactor for methanol dehydrogenase (MDH) and related enzymes that oxidize C1 compounds. The pqqD1 protein, by facilitating PQQ biosynthesis, directly enables these initial oxidation steps.

    • In engineered systems, this provides an entry point for methanol, formaldehyde, and formate into central metabolism, expanding the substrate range of P. putida .

  • Synergy with Engineered C1 Assimilation Pathways:

    • Recent studies have established formatotrophic P. putida strains by implementing the reductive glycine (rGly) pathway. PQQ-dependent enzymes can work synergistically with these engineered pathways by providing additional routes for C1 compound utilization .

    • This metabolic integration is evident in strains able to grow on glucose and methanol simultaneously, using methanol as both a carbon source and as a source of glycine and serine through the rGly pathway .

  • Regulation and Metabolic Balancing:

    • The transcriptional regulation of PQQ biosynthesis genes is integrated with C1 metabolism regulation. Analysis of transcriptomes from P. putida exposed to formate, formaldehyde, and methanol revealed differential expression patterns that coordinate these metabolic systems .

    • This coordinated regulation ensures proper balance between C1 compound oxidation and assimilation pathways.

  • Experimental Evidence from Engineered Systems:

    • The development of formate-responsive transcription factor-based biosensors has demonstrated the functional connection between PQQ-dependent methanol/formaldehyde oxidation and formate metabolism in engineered P. putida strains .

    • These biosensors have been successfully applied to detect native methanol and formaldehyde oxidation yielding formate in P. putida strains harboring the rGly pathway .

  • Metabolic Engineering Implications:

    • The integration of PQQ biosynthesis with C1 metabolism suggests potential strategies for further engineering P. putida for applications in bioconversion of C1 feedstocks, particularly methanol, which is abundant and can be produced from renewable resources .

This metabolic relationship demonstrates how PQQ biosynthesis contributes to the exceptional substrate versatility of engineered P. putida strains, particularly for utilizing non-traditional carbon sources .

What potential biotechnological applications arise from understanding pqqD1 function in recombinant systems?

Understanding pqqD1 function opens several innovative biotechnological applications:

  • Development of Methylotrophic P. putida Platforms:

    • Precise control of pqqD1 expression, as part of the PQQ biosynthetic pathway, enables the creation of robust methylotrophic P. putida strains that can utilize methanol as a carbon source.

    • This expands the feedstock range for bioproduction processes, allowing utilization of methanol derived from renewable resources or industrial waste streams .

  • Engineering Biosensors and Bioreporters:

    • Knowledge of pqqD1 and its role in PQQ biosynthesis facilitates the design of whole-cell biosensors for methanol, formaldehyde, and related compounds.

    • Such biosensors have applications in environmental monitoring, fermentation process control, and high-throughput screening systems for metabolic engineering .

  • Protein Engineering Platforms:

    • The peptide chaperone function of pqqD1 can be exploited to develop novel peptide-binding scaffolds for various biotechnological applications.

    • These applications include the development of new bioseparation technologies, protein stabilization strategies, or platforms for assembling multi-enzyme complexes.

  • Synthetic Biology Toolkit Components:

    • The regulatory elements controlling pqqD1 expression can be adapted into synthetic biology tools for controlled gene expression in P. putida and related organisms.

    • The protein-protein interaction interfaces of pqqD1 provide modular components for designing synthetic protein complexes or scaffolds in metabolic engineering applications.

  • Novel Biocatalytic Systems:

    • Understanding how pqqD1 participates in the PQQ biosynthetic pathway enables the design of artificial enzyme cascades that incorporate PQQ-dependent enzymes for specific biotransformations.

    • Such biocatalytic systems could be employed for the oxidation of alcohols, aldehydes, and sugars under mild conditions with high selectivity .

  • Metabolic Engineering Applications:

    • Optimized expression of pqqD1 and other PQQ biosynthesis proteins can enhance the production of value-added compounds in engineered P. putida strains.

    • Similar to the efficient recombinant production of prodigiosin demonstrated in P. putida, controlled expression of pqqD1 could enable high-yield production of other commercially relevant compounds .

These applications leverage both the fundamental understanding of pqqD1 function and the versatile metabolic capabilities of P. putida as a biotechnological host .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.